-
公开(公告)号:EP1667963A1
公开(公告)日:2006-06-14
申请号:EP04769377.5
申请日:2004-09-10
发明人: ASHCROFT, C.P., Pfizer Global Res. and Development , HESMONDHALGH, L.C., , GLADWELL, L.R., Pfizer Global Res. and Development , HARRIS, L.J., Pfizer Global Research & Development , HUGHS, M.L., Pfizer Global Research & Development , KLOTZ, J.T., Pfizer Global Research & Development , LEVETT, P.C., Pfizer Global Research & Development , MORLAND, M.C., Pfizer Global Res. and Development , THOMSON, N.M., Pfizer Global Res. and Development
IPC分类号: C07C319/20 , C07C323/20
CPC分类号: C07C319/20 , C07C323/20
摘要: The present invention is concerned with an improved process for the preparation of the selective serotonin reuptake inhibitor 3-[(Dimethylamino)methyl]-4-[4-(methylsulfanyl)phenoxy]benzenesulfonamide (L) or (D) tartrate (I) and with intermediate products therein.